Earth Science Tech (ETST) Non Operating Income (2018 - 2024)
Earth Science Tech (ETST) posted Non Operating Income of -$13658.0 for Q1 2024, down 144.42% on a QoQ basis from -$5588.0 in Q4 2023, and up 88.24% year-over-year from -$7255.4 in Q2 2023.
Earth Science Tech (ETST) Non Operating Income (2018 - 2024) Analysis & Trends
Earth Science Tech's Non Operating Income history runs 7 years deep, the most recent figure standing at -$13658.0 for Q1 2024.
- Quarterly Non Operating Income rose 88.24% year-over-year to -$13658.0 in Q1 2024, while the trailing twelve-month figure through Mar 2024 was -$67227.0 (down 384.02% YoY) and the FY2024 annual result came in at -$67207.0, down 111.76% from the prior year.
- Non Operating Income was -$13658.0 for Q1 2024 at Earth Science Tech, down from -$5588.0 in the prior quarter.
- Across five years, Non Operating Income topped out at $3.4 million in Q3 2021 and bottomed at -$130379.0 in Q1 2020.
- A 5-year average of $184971.8 and a median of -$12604.0 in 2020 frame the typical range for Non Operating Income.
- Annual changes were most pronounced in 2021 — Non Operating Income surged 27211.56% — and 2023, when it sank 1193.14%.
- Earth Science Tech's Non Operating Income stood at -$29793.0 in 2020, then jumped by 52.68% to -$14097.0 in 2021, then surged by 1140.92% to $146739.0 in 2022, then plunged by 103.81% to -$5588.0 in 2023, then tumbled by 144.42% to -$13658.0 in 2024.
- Business Quant data shows ETST's Non Operating Income at -$13658.0 in Q1 2024, -$5588.0 in Q4 2023, and -$35363.0 in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -216.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 20.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -7.50 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 53.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Earth Science Tech | 41.03 Mn | 38.90 Mn | 6.27 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | -13,658.00 |
| Dec 31, 2023 | -5,588.00 |
| Sep 30, 2023 | -35,363.00 |
| Jun 30, 2023 | -12,618.00 |
| Mar 31, 2023 | -116,186.00 |
| Dec 31, 2022 | 146,739.00 |
| Sep 30, 2022 | 3,235.00 |
| Jun 30, 2022 | -10,118.00 |
| Mar 31, 2022 | 37,342.00 |
| Dec 31, 2021 | -14,097.00 |
| Sep 30, 2021 | 3.39 Mn |
| Jun 30, 2021 | -10,868.00 |
| Mar 31, 2021 | -26,617.00 |
| Dec 31, 2020 | -29,793.00 |
| Sep 30, 2020 | -12,495.00 |
| Jun 30, 2020 | -12,604.00 |
| Mar 31, 2020 | -130,379.00 |
| Dec 31, 2019 | 15,987.00 |
| Sep 30, 2019 | -12,720.00 |
| Jun 30, 2019 | -164,574.00 |